Genotoxicity of theobromine in a series of short-term assays

• Published in: Mutation Research/Genetic Toxicology Vol. 169; no. 3; pp. 105 - 114
• Main Authors: Brusick, D., Myhr, B., Galloway, S., Rundell, J., Jagannath, D.R., Tarka, S.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.1986
• Subjects: Animals; Biotransformation; Caffeine - pharmacology; Cell Line; Chromosome Aberrations; Cricetinae; Cricetulus; Female; Humans; Leukemia L5178 - metabolism; Lymphocytes - drug effects; Lymphocytes - ultrastructure; Mice; Mice, Inbred BALB C; Microsomes, Liver - metabolism; Mutagenicity Tests; Ovary; Rats; Salmonella typhimurium - drug effects; Sister Chromatid Exchange - drug effects; Species Specificity; Theobromine - pharmacology
• ISSN: 0165-1218; 0027-5107
• DOI: 10.1016/0165-1218(86)90089-3

Theobromine (3,7-dimethylxanthine) was evaluated for genotoxic activity in a series of in vitro assays. Theobromine was not mutagenic in the Ames assay up to a maximum concentration of 5000 μg/plate either with or without S9 activation. The compound also failed to induce significant levels of chromosome aberrations in CHO cells (with and without S9 activation) or transformation in Balb/c-3T3 cells. At the maximum tolerated concentration theobromine increased the frequency of TK −/− mutants in mouse lymphoma L5178Y cells. Increased frequencies were observed both with and without S9 activation and they were reproducible in 2 independent experiments. Statistically significant increases in SCEs were obtained in human lymphocytes and in CHO cells under nonactivation test conditions. The spectrum of results in this battery of tests indicate that theobromine treatment results in the expression of genotoxic potential in some assays and the observed activity appears qualitatively and quantitatively similar to that of caffeine, a closely related methylxanthine.